Impact of osteoporosis tx on spinal fusion unclear

Impact of osteoporosis tx on spinal fusion unclear
The effect of osteoporosis therapies (bisphosphonate drugs and intermittent parathyroid hormone) on spinal fusion is unclear, according to a review published in the February issue of The Spine Journal.

(HealthDay)—The effect of osteoporosis therapies (bisphosphonate drugs and intermittent parathyroid hormone [PTH]) on spinal fusion is unclear, according to a review published in the February issue of The Spine Journal.

Brandon P. Hirsch, M.D., of the University of Miami/Jackson Health System, and colleagues conducted a systematic review of the literature from 1980 to 2011 to assess the potential impact of and PTH on fusion rate and quality in spinal arthrodesis. Eighteen animal studies and one clinical trial were included in the review.

The researchers found that most animal studies showed that bisphosphonates have no significant impact on fusion rate but that treatment may result in less histologically mature fusion mass; the impact of these changes on fusion mass biomechanics was unclear. Based on the human study, bisphosphonates had no impact on clinical outcome but may have increased the radiographically defined fusion rate. PTH improved the fusion rate and fusion mass microstructure in animals, but data were lacking for the effect on fusion mass biomechanics. There were no studies that assessed the impact of PTH on spine mass in humans.

"In the absence of conclusive human data relating to , we recommend the continuation or initiation of these therapies in patients based on their indication for the treatment of osteoporosis, without regard for a recent or impending spine fusion procedure," the authors write. "However, on the basis of preclinical data, we believe that anabolic agents may offer an advantage over antiresorptive medications in osteoporotic patients undergoing spine fusion."

One author disclosed to the biopharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Spinal fusion surgery not associated with stroke

date Dec 10, 2012

(HealthDay)—Undergoing spinal fusion surgery does not affect the risk of stroke within the three years after surgery, according to a study published in the December issue of the European Spine Journal.

No increased risk of stroke after spinal fusion surgery

date Aug 09, 2012

(HealthDay) -- In the three years following spinal fusion surgery, the incidence of stroke is similar to or insignificantly lower than that of controls, according to a study published in the June issue of ...

Teriparatide ups bone union for women with osteoporosis

date Nov 03, 2012

(HealthDay)—Injections of teriparatide are more effective than oral bisphosphonate for bone union after instrumented lumbar posterolateral fusion in women with postmenopausal osteoporosis, according to ...

Back pain intensity most influential in fusion decision

date Jan 24, 2013

(HealthDay)—Patients seeing a spine surgeon are most influenced by low back pain intensity when considering whether to proceed with spinal fusion surgery, according to a study published in the Jan. 15 issue ...

Recommended for you

Fighting back against superbugs

date 9 minutes ago

Antibiotics—and antibiotic resistance—are in the news once again, with announcements by McDonald's and Costco that they will eliminate antibiotics that are important to human medicine from use in the ...

Harnessing the power of microbes as therapeutics

date 1 hour ago

A new report recently released by the American Academy of Microbiology discusses how specific microbes can be modified to enhance their therapeutic potential for treating human diseases such as cancer and antibiotic resistant ...

New genetic link found for alcohol-related liver cirrhosis

date 1 hour ago

In most people, any liver damage that might occur from drinking alcohol is reversible. However, in 25 to 30 percent of alcoholics what begins as accumulation of fat in the liver progresses to inflammation, fibrosis and ultimately ...

Could camel antibodies protect humans from MERS?

date 1 hour ago

Antibodies from dromedary camels protected uninfected mice from Middle East Respiratory Syndrome (MERS), and helped infected mice expunge the disease, according to a study published online March 18th in the ...

Sierra Leone ends anti-Ebola lockdown after three days

date 5 hours ago

Sierra Leoneans were once again allowed to leave their homes Sunday evening after the government announced the end of a three-day nationwide lockdown aimed at preventing a resurgence of the deadly Ebola virus.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.